We are exploring whether a new imaging technique can better identify aggressive features in suspected low-grade gliomas without MRI contrast enhancement. This may help improve diagnosis and treatment planning for patients.
Health conditions and diseases that the clinical trial is designed to study and treat.
Low Grade Glioma is a type of slow-growing brain tumor that arises from glial cells, which support and protect nerve cells. These tumors are generally less aggressive than high-grade gliomas and can cause symptoms like headaches, seizures, and changes in cognitive function.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.